The article on the muscle bound boy who naturally has the genes that inhibit myostatin. Wikipedia on myostatin. MD Sports looks at different ways to enhance sports performance legally. They examine ...

Dr. Se-Jin Lee, who discovered the myostatin gene in 1997, said three companies, Scholar Rock, Biohaven, and Roche, have recently been testing myostatin inhibitors in phase three trials in ...

Companies are developing myostatin inhibitors for GLP-1RA- related muscle loss, but some experts doubt their necessity.

Pfizer has started phase II trials of a candidate drug to treat Duchenne muscular dystrophy (DMD) as it plays catch-up with rivals PTC Therapeutics, Prosensa and Sarepta. The pharma giant has ...

Dr. Se-Jin Lee, who discovered the myostatin gene in 1997, said three companies, Scholar Rock, Biohaven, and Roche, have ...

Last month, Scholar Rock completed enrollment in a Phase 2 trial for its myostatin inhibitor apitegromab.The EMBRAZE study is designed to show its proof-of-concept in preserving lean muscle mass ...

Our myostatin inhibitors showed significant lean body mass preservation, with both daily and weekly oral administration, effectively counter-acting the lean mass loss associated with semaglutide ...

We may also note that both Roche and Biohaven have late-stage studies of myostatin inhibitors ongoing—Roche is hoping to achieve approval after 2027, however, and Biohaven's candidate ...

Preclinical model testing showed that myostatin inhibitor taldefgrobep alfa + GLP-1 inhibitor was able to show greater reductions in body weight and fat loss compared to that of GLP-1 alone.

Myostatin inhibition is a very safe mechanism for weight loss and muscle preservation, and patients typically have no adverse effects, says Dr. Martin Brenner, the CEO at iBio.

Dr. Se-Jin Lee, who discovered the myostatin gene in 1997, said three companies, Scholar Rock, Biohaven, and Roche, have recently been testing myostatin inhibitors in phase three trials in ...